Mülheim/Ruhr, Germany

Chantal Fürstner


Average Co-Inventor Count = 10.4

ph-index = 6

Forward Citations = 126(Granted Patents)


Location History:

  • Mülheim/Ruhr, DE (2002)
  • Ruhr, DE (2002)
  • Mülheim an der Ruhr, DE (2002)
  • Mühlheim, DE (2003)

Company Filing History:


Years Active: 2002-2003

Loading Chart...
7 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Chantal Fürstner:

Title: Innovator Spotlight: Chantal Fürstner Revolutionizing CNS Disease Treatment

Introduction: Chantal Fürstner, based in Mülheim/Ruhr, DE, is a prolific inventor with a total of 7 patents to his name. His groundbreaking work has significantly impacted the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) diseases.

Latest Patents:

1. 3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases: Chantal Fürstner's latest patent introduces novel compounds for use in prophylaxis and treatment of cognitive disorders, cerebral infarct, trauma, and pain associated with CNS diseases like Alzheimer's and dementia.

2. Heterocyclylmethyl-substituted pyrazole derivatives: This patent showcases innovative derivatives with potential applications in cardiovascular disease treatment, illustrating Fürstner's diverse expertise in pharmaceutical development.

Career Highlights: Chantal Fürstner's impressive career is highlighted by his association with Bayer Aktiengesellschaft, a renowned pharmaceutical company known for its contributions to healthcare worldwide. His contributions to Bayer's research and development team have been instrumental in advancing novel therapeutic solutions for complex medical conditions.

Collaborations: In his professional journey, Chantal Fürstner has collaborated closely with talented individuals such as Alexander Straub and Thomas Jaetsch. Their combined expertise and innovative thinking have fueled the success of various projects and paved the way for new advancements in medicine.

Conclusion: Chantal Fürstner's dedication to innovation and his relentless pursuit of novel solutions for challenging CNS diseases have established him as a key figure in the pharmaceutical industry. His patents serve as a testament to his visionary approach towards improving healthcare outcomes and shaping the future of medicine.

If you have any more specific requests or need further information, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…